Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies with attractive risk-reward profiles. Our valuation framework helps you find stocks with the right balance of growth and value characteristics for your portfolio. We provide P/E analysis, PEG ratios, and relative valuation metrics for comprehensive valuation coverage. Find value in growth with our comprehensive valuation analysis and multiples tools for growth at a reasonable price strategies.
Dermata Therapeutics Inc. (DRMA), a clinical-stage small-cap biotech firm, is trading at a current price of $1.31 as of 2026-04-06, posting a 1.94% gain during the most recent trading session. This analysis examines key technical levels, recent market context, and potential near-term scenarios for DRMA as investors and traders monitor price action amid mixed sentiment across the broader biotech sector. No recent earnings data is available for the company as of this analysis, so near-term price m
Is Dermata (DRMA) Stock Near Resistance | Price at $1.31, Up 1.94% - Price Action
DRMA - Stock Analysis
3855 Comments
866 Likes
1
Jaide
Regular Reader
2 hours ago
This is why timing is everything.
👍 290
Reply
2
Kentrail
Legendary User
5 hours ago
This would’ve saved me from a bad call.
👍 227
Reply
3
Kymire
Active Contributor
1 day ago
Expert US stock picks delivered daily with complete analysis and risk assessment to support informed investment decisions. Our recommendations span multiple time horizons and investment styles to accommodate different risk tolerances and financial goals.
👍 13
Reply
4
Shahriar
Influential Reader
1 day ago
Price action remains choppy, with intraday fluctuations reflecting a mix of buying and selling pressure.
👍 246
Reply
5
Jozie
Engaged Reader
2 days ago
Overall market trends remain stable, though intermittent corrections may occur.
👍 226
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.